Paolo Galfetti is President of Relief Europe. He has over 20 years of management experience in the pharmaceutical sector, including in the areas of business development and licensing, operational strategic management, clinical research, and pharmaceutical discovery and development. He joined APR Applied Pharma Research SA in 1995 (acquired by Relief in June 2021) as head of licensing and business development and was appointed CEO in 2002. Under his leadership, APR has brought its first product onto the market and developed a rich pipeline of product candidates. Paolo also was a founding partner, CEO and board member of the Institute for Pharmacokinetic and Analytical Studies AG (IPAS), a Swiss contract research organization, as well as CEO and board member of Farma Resa s.r.l., an Italian CRO, and the member of several Pharma licensing groups. Paolo is a Chartered Financial Analyst (CFA) and has a bachelor’s degree in economics from the Commercial University Bocconi, Milan, Italy.